TAME Trial Presentation
Critical Care Reviews Podcast
00:00
The Results of the TTM 2 Trial
From March 2018 through to September 2021, we enrolled 1,700 patients from 63 intensive care units in 17 countries. Of this, 370 were co-enrolled with the TTM 2 trial. This represents 21% of the patient population. And as expected, we achieved a less than 5% loss to follow up for our dichotomised ghost and similar number of patients provide full ghost data at 6 months.
Transcript
Play full episode
